Frontiers in Pediatrics · 2017 · 16 citations · 16 references
MedicineCardiologyPediatricsCritical Care CardiologyPediatric CardiologyPediatric TherapeuticsCardiopulmonary BypassExtracorporeal CirculationExtracorporeal Life SupportExtracorporeal Membrane OxygenationHeart FailurePediatric Cardiac SurgeryCardiopulmonary Bypass In InfantsLong-term Survival After Congenital Heart SurgeryOrgan Failure ManagementPediatric Cardiopulmonary BypassPediatric Extracorporeal Life SupportPediatric Extracorporeal Membrane OxygenationPostoperative Low Cardiac Output SyndromeTherapeutic Plasma Exchange
Background: Thrombocytopenia-associated multi organ failure (TAMOF) in children is a well described factor for increased hospital mortality. Low cardiac output syndrome (LCOS) and the effects of cardiopulmonary bypass (CPB) may manifest with several adverse physiologic and immunologic effects, with varying degrees of thrombocytopenia and multiorgan dysfunction, sometimes very similar to TAMOF. LCOS is a common occurrence in children with critical heart disease, presenting in as much as 23.8% of infants postoperative of congenital heart surgery. Therapeutic plasma exchange (TPE) has been offered as a promising therapy for TAMOF; however, the therapeutic implications of this modality in children with critical heart disease and a clinical diagnosis of TAMOF are unknown. Objectives: We describe our institutional experience with TPE as an adjuvant rescue therapy for children with critical heart disease and a clinical diagnosis of TAMOF, while supported by extracorporeal membrane oxygenation (ECMO). Methods: Single-center retrospective analysis of children with critical heart disease admitted to the CICU and supported by ECMO, undergoing TPE for a clinical diagnosis of TAMOF between January 2006 and June 2015. Results: 41 patients were included for analysis. Median age and weight of patients was 0.6 years (range 0.0-17.2) and 8.5 kg (range 1.5-80.0). TPE was initiated at a median of 1 day (0-13) after initiation of ECMO. Modified organ failure index (MOFI) and platelet count improved after TPE start (p<0.001). Patients with early TPE initiation after ECMO cannulation (<1 day) showed more improvement in MOFI and platelet counts than patients with late TPE initiation (p<0.001 for each). Overall survival to hospital discharge was 53.7%. The within-groups hospital survival was 73.3% for patients with heart failure, 34.8% for patients with congenital heart disease and 100% for those with other cardiac disease (p= 0.016). Conclusion: In children with critical cardiac disease and clinical diagnosis of TAMOF necessitating ECMO for hemodynamic support, concurrent TPE may be associated with an improvement in organ failure and platelet count, particularly when started early. Further studies are warranted to establish the most effective use of TPE and its effect on survival in this population.
16
Systemic inflammatory response syndrome after cardiac operations
Joachim Cremer, MARIUS MARTIN, Heinz Redl et al. · The Annals of Thoracic Surgery · 1996 · 526 citations
Time course of platelet counts in critically ill patients
Serdar Akça, Philip Haji-Michael, Arnaldo de Mendonça et al. · Critical Care Medicine · 2002 · 407 citations
Trung C. Nguyen, Yong Han, Joseph E. Kiss et al. · Critical Care Medicine · 2008 · 207 citations · Full text